Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma.
Nagane M; Nishikawa R; Narita Y; Kobayashi H; Takano S; Shinoura N; Aoki T; Sugiyama K; Kuratsu J; Muragaki Y; Sawamura Y; Matsutani M; Japanese Journal Of Clinical Oncology, 2012, vol. 42, issue 10, p 887, ISSN 14653621. ISBN 14653621.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef